News
Digital hypnotherapy company raises US$12m to help women manage their health
Studies have shown hypnosis-based therapy to be effective in managing symptoms of menopause and IBS

An Australian digital hypnotherapy company has raised US$12m to expand its offerings and help women manage their health.
Mindset Health, which currently has three hypnotherapy apps dedicated to addressing irritable bowel syndrome (IBS), menopause and smoking cessation, aims to help people improve their health and live well with “underserved” health conditions.
Funding from this latest round, led by King River Capital, will support the growth and development of its current apps as well as the launch of new apps in response to market demand for solutions for anxiety, depression, sleep and chronic pain.
Additionally, the capital will allow the Australian company to continue its clinical research programmes in partnership with Baylor University and Monash University.
“The global demand for our hypnotherapy programmes – driven by healthcare practitioners, who recognise their effectiveness in supporting patients and recommend their use – has proven our thesis and demonstrated the deep market appetite for easy to use solutions that can help people manage and live well with underserved health conditions,” said Mindset Health co-founder, Alex Naoumidis.
“This latest financing will support us to continue to meet that demand and in new areas with a broader product offering, as well as funding additional research programmes instrumental to producing high-quality digital programmes backed by clinical rigour.
“Our brains can influence our immune system, our heart health, our habits and our pain perception – our mission is to help unlock this potential of the mind to change how we think, feel and act.”
Referrals from doctors, dietitians and other providers are largely organic via word of mouth but are already driving significant growth, the founder explained.
Not only do healthcare providers act as a scaling growth channel, retrospective studies show that users who are referred by a healthcare practitioner are significantly more likely to adhere to the program long-term.
Studies have shown hypnosis-based therapy to be effective in helping to manage many chronic health conditions, including IBS, menopause and chronic pain.
“By automating hypnosis-based therapies, Mindset Health is utilising the very qualities that have made traditional approaches so successful – efficient scalability, on-demand availability, and clinical rigour – without the side effects, or the billion-dollar R&D price tag,” said Chris Barter, co-founder and partner of King River Capital.
“It’s a total game-changer in the way it’s helping people around the world take control of their health and successfully address a range of chronic conditions naturally and holistically.”
News
Perimenopause may offer “window of opportunity” for heart disease prevention
News
Research project of the year shortlist revealed

The Femtech World Awards is proud to reveal the shortlist for Research Project of the Year as part of the third annual global celebration of innovation, impact and leadership across women’s health.
From fertility science and perimenopause research to regional ecosystem analysis, the shortlisted projects reflect the breadth and growing influence of femtech research worldwide.
The category is sponsored by OncoGenomX, with the winner to be selected by a representative from the organisation.
OncoGenomX is dedicated to offering solutions and providing comprehensive support services that empower Drug Developers, Clinical Researchers, Oncologists,NextGenSeq Diagnostics Laboratories, NextGenSeq Service Organisations, Cancer Diagnostics and Therapeutics Companies to achieve their ambitious goals
The shortlisted entries for Research Project of the Year are:

Women’s health remains significantly underserved in South-East Asia, with persistent gaps in access, awareness, and quality of care carrying substantial social and economic costs.
This report examines the femtech landscape in Indonesia, the Philippines, Singapore, Thailand, and Vietnam, highlighting market trends, emerging technologies including artificial intelligence, and the evolving support ecosystem.
It identifies key challenges facing femtech founders, including limited access to finance, low awareness and persistent stigma, marketing constraints linked to content moderation, and gaps in tailored ecosystem support.

Led by Stephanie Willson, MD, of the IVI RMA Global Research Alliance, the study explored whether embryos that show certain chromosome abnormalities during genetic testing may still have the potential to result in a healthy pregnancy and live birth.
The research analysed more than 7,600 frozen embryo transfers and found that some embryos previously considered unlikely to succeed were still capable of leading to successful pregnancies, although at lower rates than embryos without abnormalities.
The findings could help fertility clinics and patients make more informed decisions during IVF treatment, particularly in cases where there are limited embryos available.
Rather than automatically discarding these embryos, the research supports a more evidence-based and personalised approach to fertility care.

For many women, perimenopause can feel confusing and unpredictable, with limited research explaining what is happening in their bodies.
Natural Cycles set out to change that by leading one of the largest studies ever conducted on menstrual and ovulatory patterns, uncovering new insights into how ovulation behaves as women approach menopause.
Conducted in collaboration with researchers from George Washington University, Seattle Clinical Research Center, Gennev and the University of California San Diego, the study analysed nearly one million menstrual cycles from more than 197,000 women aged 18–52 across more than 140 countries.
The scale of this dataset made it possible to explore menstrual patterns and ovulation in far greater detail than has traditionally been possible in women’s health research.
The Femtech World Awards celebrates the innovators, researchers and organisations driving meaningful progress in women’s health.
What happens next
Winners across all categories will be revealed during the virtual ceremony on June 19, with winners receiving a trophy and an interview with a Femtech World journalist.
Wellness
Women over 40 seeking raves for mental health benefits
Entrepreneur3 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur2 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility4 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Diagnosis3 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Mental health4 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health3 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News3 weeks agoResistance training has preventative effects in menopause, study finds
Pregnancy3 weeks agoNIPT or NT scan? Why the 2026 evidence supports doing Both















1 Comment